Related Experiment Video
Updated: Jun 13, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
High mobility group box-1 and cardiovascular diseases
1Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University & Yichang Central People's Hospital, Yichang, The People's Republic of China.
Saudi Medical Journal
|May 14, 2010
Summary
High mobility group box-1 (HMGB1) protein is crucial for inflammation and tissue repair. This review details HMGB1's significant role in various cardiovascular diseases, including heart attack and heart failure.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- High mobility group box-1 (HMGB1) is a ubiquitous nuclear and cytoplasmic protein.
- HMGB1 acts as a mediator of inflammation and promotes tissue repair after release from necrotic cells or activated immune cells.
Purpose of the Study:
- To review the association between HMGB1 and cardiovascular diseases.
- To highlight HMGB1's pivotal role in cardiac pathologies.
Main Methods:
- Literature review of recent studies on HMGB1 and cardiovascular diseases.
- Summarization of HMGB1's functions in inflammation and tissue repair relevant to the cardiovascular system.
Main Results:
- HMGB1 is implicated in atherosclerosis.
- HMGB1 plays a role in myocardial ischemia/reperfusion injury.
- HMGB1 is associated with heart failure and myocardial infarction.
Conclusions:
- HMGB1 is a key factor in the pathogenesis and progression of cardiovascular diseases.
- Understanding HMGB1's role may offer therapeutic targets for cardiovascular conditions.
- Further research is warranted to fully elucidate HMGB1's mechanisms in cardiovascular disease.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...